JAKARTA, INDONESIA (8 November 2022)— The Asian Development Bank (ADB) has subscribed to around 1 billion shares, worth $12.2 million (approximately 190 billion Indonesian rupiah), as part of the initial public offering (IPO) of PT Jayamas Medica Industri (OneMed) on the Indonesian Stock Exchange.
The proceeds of the IPO will support operational expansion across OneMed’s value chain by doubling the manufacturing facilities from two to four, the number of national distribution centers from one to two, adding 15 warehouses, and 25 new retail stores. The availability of affordable medical equipment and supplies is critical for the sustainability and expansion of Indonesia’s national health insurance program, Jaminan Kesehatan Nasional.
“Developing domestic production is a pivotal step toward self-sufficiency for health care in Indonesia,” said ADB Private Sector Operations Department's Unit Head of Health and Education Investments Aniruddha Patil. “Supporting OneMed’s strong local presence in Indonesia will help strengthen Indonesia’s health care resilience and deliver better health outcomes for its citizens.”
“We greatly appreciate ADB’s support for our IPO and I look forward to working with the bank,” said OneMed President Commissioner Jemmy Hartanto. “The investment will help sustain OneMed’s commitment to support universal health care in Indonesia and to improve the overall level of health care in the country.”
Established in 2002, OneMed is the largest manufacturing and distribution company of medical equipment and supplies in Indonesia, covering 514 cities and 34 provinces. OneMed has the most comprehensive portfolio of medical equipment and supplies in the country, with key products including syringes, medical gloves, antiseptics and disinfectants, and infusion sets.
ADB is committed to achieving a prosperous, inclusive, resilient, and sustainable Asia and the Pacific, while sustaining its efforts to eradicate extreme poverty. Established in 1966, it is owned by 68 members—49 from the region.
